HomeMarkets overviewSharesPuma Biotechnology, Inc.

Trade Puma Biotechnology, Inc. - PBYI CFD

Market is not available at the momentMarket information is presented
as of 2026-09-11T19:47:20+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.0964
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021485 %
(-$4.30)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


-0.02149%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000738 %
(-$0.15)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


-0.00074%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity10
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close9.1368
Open9.0068
1-Year Change98.65%
Day's Range8.8968 - 9.0668

Trade Puma Biotechnology, Inc. - PBYI

What is Puma Biotechnology (PBYI)?

Puma Biotechnology, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of various cancers. Founded in 2010, the company specializes in targeted oncology drugs, particularly in the areas of breast cancer and other solid tumors. Puma Biotechnology's research and development efforts include advancing compounds through clinical trials to address unmet medical needs. The company collaborates with medical institutions and regulatory agencies to bring new therapies to market. Headquartered in Los Angeles, California, Puma Biotechnology operates within the biotechnology sector, emphasizing precision medicine and personalized treatment approaches.

Puma Biotechnology Stock Price Today: Live Overview

The price today is shaped by market movement, with Puma Biotechnology priced at $9.1532. Intraday fluctuations range from $8.7768 to $9.1368, with a daily change of -1.5356%.

FAQ: Puma Biotechnology (PBYI)

What is the current price of PBYI stock?

The current price stands at $9.1532.

Does PBYI pay dividends?

Dividends are not paid by the company.

Does PBYI have a formal corporate presence or regional headquarters in the UAE?

Puma Biotechnology does not have an official regional office or subsidiary in the UAE and operates through distributors only.

What is PBYI best known for?

Puma Biotechnology is most famous for its development of oncology drugs.

What assets are typically shown together with PBYI?

Commonly shown alongside PBYI: NY Times, Workday, JFrog Ltd.

Latest shares articles

Palantir shares prediction
Palantir stock forecast: Nebius AI infrastructure partnership
Palantir Technologies is a US software company. On 8 September 2026, it named Nebius Group its preferred sovereign AI infrastructure partner. Explore third-party PLTR price targets and technical analysis. Past performance is not a reliable indicator of future results.
21 hours ago
Oracle logo displayed on the exterior of a modern office building with blue glass windows under a clear sky.
Michael Kramer: How to Analyse Oracle Before Earnings
Oracle’s market capitalisation has risen from roughly $165 billion in late 2022 to roughly $430 billion on 31 August 2026, after peaking at $935 billion in September 2025.
08:45, 7 September 2026
Diginex Stock Forecast
Diginex stock forecast: Resulticks deal, funding commitments
Diginex has agreed to acquire Resulticks for $1.05 billion in shares, with $70 million in private funding commitments and completion targeted for 30 October 2026, subject to approvals. Explore third-party price targets and technicals. Past performance is not a reliable indicator of future results.
12:03, 1 September 2026
Stellantis flag
Stellantis stock forecast: Third-party price targets
Stellantis is reviewing the future of its Brampton, Ontario plant, with Unifor saying closure or sale is under consideration amid US tariff pressures. Explore third-party STLAM price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:35, 1 September 2026

User feedback and ratings

2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-27
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-06-19
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-05-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready